Special Issue "Breast Cancer: Future Biomarkers and Personalizing Treatment Approaches"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 7233
Interests: breast cancer; oncology; pharmacology
Interests: cardio-oncology; inflammation; chemoresistance; radioresistance; nanotechnology; endocrine disruptor
Special Issues, Collections and Topics in MDPI journals
Breast cancer is a heterogeneous disease characterized by variant pathological features, disparate responses to therapeutics. During recent years, several new therapies such as PARP inhibitors, immune checkpoint inhibitors, CDK-4/6 inhibitors, and new HER-2 blocking agents, have been integrated into clinical practice, significantly improving the survival of breast cancer patients. However, many patients could early relapse due to the absence of predictive biomarkers of response and resistance to these new agents. This Special Issue welcomes the field of personalizing medicine in breast cancer, covering interdisciplinary health research, preclinical models, translational and clinical research.
Dr. Stefania Cocco
Dr. Vincenzo Quagliariello
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- breast cancer
- prognostic and predictive medicine
- biochemical pathways
- gene signature
- precision medicine
- target therapy